BI 201335, A POTENT HCV NS3 PROTEASE INHIBITOR, IN TREATMENT-NAIVE AND -EXPERIENCED CHRONIC HCV GENOTYPE-1 INFECTION: GENOTYPIC AND PHENOTYPIC ANALYSIS OF THE NS3 PROTEASE DOMAIN

被引：17

作者：

Kukolj, G. ^{[1
]}

Benhamou, Y. ^{[2
]}

Manns, M. P. ^{[3
]}

Bourliere, M. ^{[4
]}

Pol, S. ^{[5
]}

Schuchmann, M. ^{[6
]}

Cartier, M. ^{[1
]}

Huang, D. ^{[7
]}

Lagace, L. ^{[1
]}

Steinmann, G. ^{[8
]}

Stern, J. O. ^{[7
]}

机构：

[1] Boehringer Ingelheim Canada Ltd, Biol Sci, Laval, PQ, Canada

[2] Hop La Pitie Salpetriere, Serv Hepatogastroenterol, Batiment Clin Med, Paris, France

[3] Hannover Med Sch, Zentrum Innere Med, Abt Gastroenterol Hepatol & Endokrinol, D-30623 Hannover, Germany

[4] Hop St Joseph, Serv Hepatogastroenterol, Marseille, France

[5] Hop Cochin, Unite Hepatol, F-75674 Paris, France

[6] Johannes Gutenberg Univ Mainz, Med Klin & Poliklin 1, Klinikum Johannes Gutenberg, D-6500 Mainz, Germany

[7] Boehringer Ingelheim Pharmaceut Inc, Virol, Ridgefield, CT 06877 USA

[8] Boehringer Ingelheim Pharma GmbH & Co KG, Clin Res, Virol, Biberach, Germany

来源：

关键词：

D O I：

10.1016/S0168-8278(09)60956-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

954

引用

页码：S347 / S347

页数：1